A new radioanalytical method was developed for rapid determination of 226 Ra in human urine samples. The method is based on organic removal and decolourisation of a urine sample by a polymeric (acrylic ester) solid phase sorbent material followed by extraction and preconcentration of Ra in human urine samples as defined in the requirements for radiation emergency bioassay techniques for the public and first responders based on the dose threshold for possible medical attention recommended by the International Commission on Radiological Protection (ICRP). The accuracy (expressed as relative bias, B r ) and repeatability of the method (expressed as relative precision, S B ) evaluated at the reference level (2 Bq l 21 ) were found to be 24.5 and 2.6 %, respectively. The sample turnaround time was <5 h for a single urine sample and <20 h for a batch of six urine samples. With the fast sample turnaround time combined with the potential to carry out the analysis in a field deployable mobile laboratory, the newly developed method can be used for emergency radiobioassay of 226 Ra in human urine samples following a radiological or nuclear accident.
INTRODUCTION
Internal exposure of radium can cause bone sarcomas and carcinomas of the perinasal sinuses and mastoid air cells (often called head cancers) (1) . Radium decay products, primarily radon and its short-lived daughters also have the potential to cause lung cancer (2) . 226 Ra has been identified by the International Atomic Energy Agency as one of the radionuclides that can cause harm to human health if used in a malicious activity such as a terrorist attack using a radiological dispersion device (3) . The Canadian government has funded two projects to develop rapid, sensitive and field-deployable bioassay techniques for emergency population monitoring through its chemical, biological, radiological, nuclear agents and explosives (CBRNE) research and technology initiatives (CRTI) programme (4) . Analytical requirements for the emergency bioassay techniques have been developed for the radionuclides of interests (4, 5) . Under these CRTI projects, a number of emergency radiobioassay methods for 90 Sr (6, 7) and 241 Am (8, 9) in urine and 239 Pu (10) in faecal samples have been recently developed. In this paper, an emergency radiobioassay method for 226 Ra in human urine samples is described.
Analytical methods (Ra-04-RC and Ra-06-RC) described in the United States Department of Energy Environmental Measurements Laboratory (EML) procedures manual for determination of 226 Ra in urine samples require tedious and timeconsuming sample preparation steps such as wet digestion (in the case of Ra-04-RC), barium-radiumsulphate co-precipitation and equilibration time (30 d) for 222 Rn, 218 Po and 214 Po to be in secular equilibrium with 226 Ra (in case of Ra-06-RC) (11) . It can take from 2-3 d (in case of Ra-04-RC) to over a month (in the case of Ra-06-RC) to analyse one urine sample. Kehagia et al. (12) have used lead sulphate co-precipitation to preconcentrate 226 Ra from a urine sample followed by its purification through anion and cation exchange techniques. The sample preparation (i.e. evaporation to dryness, co-precipitation, purification by anion and cation exchange techniques and electrodeposition for alpha spectrometry) takes 2 d for a batch of four samples. More recently, Cozzella et al. (13) have described a method where 226 Ra was preconcentrated (from urine samples) via co-precipitation on manganese dioxide (MnO 2 ) followed by purification on cation exchange resin and an inductively coupled plasma quadrupole mass spectrometric quantification technique. The experimental procedure including sample preparation and quantification also took 2 d for a batch of four urine samples. The radiobioassay methods described above (11 -13) are more suitable for measuring internal contamination of 226 Ra in environmental or occupational exposure where the activity of 226 Ra in urine is very low (in mBq l 21 level) and the number of people required to be monitored for internal contamination will not overwhelm the existing capability and capacity of the radiobioassay laboratories.
However, in a radiological emergency involving 226 Ra, a rapid radiobioassay method will be needed to screen a large number of people to assess their internal radiation exposure and to decide on the subsequent protective action.
In this study, a newly developed radiobioassay method based on dispersive liquid-liquid microextraction (DLLME) of 226 Ra from human urine samples is presented. Unlike a conventional liquidliquid extraction (LLE), in DLLME a small volume of an organic solvent is dispersed into the aqueous urine sample in the form of an emulsion. The emulsified fine droplets provide a large surface area to enhance contact between the extractant in the organic phase and the analyte in the urine sample. The enhanced mass transfer process for the analyte (from aqueous to organic phase) gives rise to better extraction efficiency in a much shorter extraction time compared with conventional LLE. Measurement of 226 Ra was carried out using a liquid scintillation counting (LSC) instrument with the alpha/beta (a/b) separation capability. Contrary to the existing analytical methods, faster extraction and preconcentration of 226 Ra using DLLME and higher counting efficiency of LSC (compared with alpha or gamma spectrometry) resulted in a rapid radiobioassay method with a sample turn around time of ,5 h.
MATERIALS AND METHODS

Chemicals and reagents
Acetonitrile, toluene, dibenzo-21-crown-7, hexafluoroacetylacetone, sodium chloride, sodium nitrate, sodium perchlorate, sodium thiocyanate and sodium citrate tribasic dihydrate used for DLLME were purchased from Sigma-Aldrich Canada (Oakville, ON, Canada 226 Ra to urine matrix, it was placed in an ultra-sonic bath (Branson Ultrasonic Corporation, Danbury, CT, USA) and sonicated for 30 min at 42 kHz (frequency) and 100 W (power). The spiked urine was passed through the column packed with the Pre-Filter resin at a flow rate of 1-2 ml min 21 . The urine sample coming out of the column was collected in a 125-ml polypropylene bottle placed inside the vacuum box and the flow was adjusted through the controller of the vacuum inlet.
Procedure for determination of 226 Ra in urine samples
A 40-ml aliquot of the spiked ( 226 Ra) and homogenised urine sample was passed through the Pre-Filter Resin column (as described above) at a flow rate of 1 -2 ml min
21
. The column was rinsed by passing 30 ml of 1 % HCl through at the same flow rate. The urine sample and the rinse solution (1 % HCl) coming out of the column were collected in a 125-ml polypropylene bottle ( placed inside the vacuum box). Sodium thiocyanate and sodium citrate were added to provide a concentration of 0.1 and 0.02 M, respectively, for a final volume of 80 ml. The pH of the solution was adjusted to 7.0 + 0.5 using sodium hydroxide (5 M) solution. The final volume of the solution was adjusted to 80 ml (by adding deionised water) and was transferred to a 100-ml glass volumetric flask. A mixture of disperser solvent (12 ml of acetonitrile per sample) and organic extractant (1.6 ml of toluene containing 0.2-M hexafluoroacetylacetone and 0.05-M dibenzo-21-crown-7 per sample) was prepared in a polypropylene bottle. A 13.6 ml of this mixture was added to the sample solution (in the volumetric flask) using a single piston solvent delivery pump at a flow rate of 6.0 ml min 21 . The cloudy emulsion so formed was allowed to equilibrate for 10 min in an ultrasonic bath. Separation of the organic and aqueous phases through de-emulsification was carried out by adding 12 ml of acetonitrile using the same pump at a flow rate of 6 ml min 21 . Organic phase ( 1.6 ml) that floated on the top of the urine sample was conveniently collected from the narrow neck of the volumetric flask using a 5-ml Hamilton GasTightw Syringe (with a 22-gauge blunt end needle). The organic phase was mixed with a liquid scintillation (LS) cocktail (MaxiLight, Hidex Oy, Turku, Finland) to provide a final volume of 20 ml in a scintillation counting sample vial ( polypropylene, 20 ml). It was then homogenised using a vortex mixer.
The measurement of 226 Ra was carried out on a Hidex 300 SL automatic TDCR LS counter in a/b separation mode for a counting time of 2 h. The other parameters used in a/b separation mode in LSC were alpha delay time (40), alpha tail offset (2), pulse length index or PLI (14) , Y gain (40) and region of interest or ROI (680-760 channels).
Activity (A in Bq l 21 ) of 226 Ra in the urine sample was determined using the following equation:
where N is the net count (gross count minus method blank prepared in urine that was not spiked with 226 Ra), t is the counting time (in s), h is the counting efficiency of the LS counter, Y is the chemical yield, V is the sample volume (in l) and E C is the combined efficiency for LS counter (counting efficiency) and chemical yield.
A combined efficiency, E C , can be determined from the spike recovery where a second aliquot (40 ml) of the urine sample was spiked with a known activity of 226 Ra using the following equation:
where N* is the net count of the spike, t is the counting time (in s), M* is the amount of the spike solution (in g) and A* is the specific activity (in Bq g
) of the spiking solution. However, for higher combined efficiency, E C ! 0.9, it can be reasonably assumed to be 1 and can be neglected from Equation 1.
Procedure for studying selectivity
In order to study the selectivity for the extraction of 226 Ra from its alpha-emitting daughter progenies (namely, 222 Rn, 218 Po and 214 Po), the urine sample that had been measured in the LSC for 2 h (as described above) immediately after the extraction and preconcentration was stored for 30 d. After 30 d, the sample was measured again for 2 h in the LSC. The selectivity (for extraction of 226 Ra from its daughter progenies) was demonstrated by comparing the LSC energy spectra before and after storage.
The selectivity for extraction of 226 Ra from urine samples was also studied in the presence of actinides (namely, 233 
RESULTS AND DISCUSSION
DLLME method development
A DLLME-based extraction and preconcentration technique for 226 Ra from drinking water samples have been developed. The detail of the method is described in a separate paper (14) . When the procedure was applied to urine samples some problems were encountered. During the addition of 0.8 mmol NaOH (to neutralise 2-thenoyltrifluoroacetone), the pH of the solution increased to 11.5 and materials in the urine sample started to precipitate. As a result, additional NaOH (0.8 mmol) was not used in the urine samples. Moreover, emulsification and de-emulsification were also affected by the presence of the urine matrix (mainly organics) and consequently prevented collection of the organic phase after de-emulsification. It was, thus, necessary to treat the urine sample in order to remove the organics that were interfering with the DLLME process. It was also necessary to decolourise urine samples in order to remove the organics that would otherwise contribute to colour quenching in LSC. Pre-filter Resin was successfully used in the previously developed 90 Sr emergency radiobioassay method to decolourise the urine samples (6) . When treated with the Pre-filter Resin (in this study), as described in the experimental procedure, the urine samples were decolourised, the problems in the emulsification and de-emulsification were solved, and consequently, the DLLME process was resumed. However, when the spiked urine samples treated with Pre-filter Resin were subjected to the DLLME procedure, recovery of 226 Ra was not satisfactory (75 %). The DLLME procedure, therefore, needed to be further modified for urine samples as described below.
Modifications to the DLLME procedure for urine samples
In order to improve 226 Ra recovery, the DLLME procedure was modified by (1) using a different co-ligand, hexafluoroacetylacetone, instead of 2-theonyltrifluoroacetone, (2) lowering the pH of the solution from 8.5 to 7.0 + 0.5, (3) introducing a rinse step in the organic removal and decolourisation and (4) varying the inorganic salt additives as described below.
Use of hexafluoroacetylacetone and lowering of pH
The optimum equilibrium pH in the previous DLLME procedure was 8.4 . The co-ligand, 2-thenoyltrifluoroacetone acted as an organophilic counter anion for Ra 2þ and needed to be in its deprotonated (negatively charged) form in order to be partitioned from the non-polar organic phase to polar aqueous phase. The additional 0.8-mmol NaOH (in the previous DLLME procedure) was necessary to neutralise the acidity of 2-theonyltrifluoroacetone (0.2 M in 4 ml of toluene) which then would become deprotonated (negatively charged) and would partition into the aqueous phase when introduced through the organic phase. To remain in a completely deprotonated form, the equilibrium pH during emulsification needed to be two units above the pKa (6.4) of 2-thenoyltrifluoroacetone. However, since the additional (0.8 mmol) NaOH raised the pH of the urine to 11.5 and caused it to precipitate out of solution, it was decided to replace 2-thenoyltrifluoroacetone with a similar beta-diketone that has lower pKa value. Compared to 2-thenoyltrifluoroacetone ( pKa ¼ 6.4), hexafluoroacetylacetone is a relatively stronger acid with a pKa of 4.35 (15) . Replacing 2-thenoyltrifluoroacetone (0.2 M) with 0.2-M hexafluoroacetylacetone, the equilibrium pH was found to be 6.4 + 0.3 when the pH (after decolourisation and organic removal) was adjusted to 7.0 + 0.5. At an equilibrium pH of 6.4 + 0.3, hexafluoroacetylacetone would be completely deprotonated in the aqueous (urine) phase. As a result, while the ligand, dibenzo-21-crown-7 would chelate Ra 2þ , hexafluoroacetylacetone would act as an organophilic counter anion to neutralise the charge on Ra 2þ in order to transport it back to the organic phase. Carrying out the DLLME at a pH close to the physiological pH of human urine, the integrity of urine matrix in terms of its homogeneity was maintained as well.
Addition of a rinse step
The Pre-filter Resin is a moderately polar polymeric (acrylic ester) sorbent material and can retain some of the Ra 2þ due to the electrostatic attraction during the loading process, consequently resulting in lower recovery of 226 Ra. Some of the Ra 2þ could also be left in the void volume (interstitial space) within the resin material. A rinse with a relatively polar 1 % HCl solution seemed to be a rational choice to compensate for either of the two processes. When a 10 ml volume of 1 % HCl was used to rinse the column, the recovery of 226 Ra increased from 75 % (no rinse) to 90 %. When the rinse volume was gradually increased from 10 to 30 ml (in 10-ml increment), a rinse volume of 30 ml was found to provide quantitative recovery (95.5 + 2.6 %) of 226 Ra.
However, in many cases a rinse volume of 20 ml would be adequate (.90 % recovery) when the sample processing time is more critical. Nonetheless, a rinse volume of 30-ml HCl was used in the subsequent DLLME procedure.
Inorganic salt additives
Although, adequate recovery of 226 Ra was obtained from the urine samples when 0.1-M sodium perchlorate was used as an inorganic salt additive in the DLLME process, separation of the energy zones for alpha and beta emitters was somewhat poorer. The PLI used to set the discriminator for a/b separation in the Hidex 300SL LSC is affected by poor separation of the alpha-and beta-energy channels and introduces interference from the beta pulse to the alpha pulse and vice versa. A number of inorganic salt additives (sodium chloride, sodium perchlorate, sodium thiocyanate and sodium nitrate) were tested and sodium thiocyanate was found to be a slightly better choice in terms of separation of the alphaand beta-energy channels. Also, as shown in Figure 1 , the recovery of 226 Ra from urine samples was better when 0.1-M sodium thiocyanate was used compared with the others.
Analytical figures of merit
Minimum detectable activity
The minimum detectable activity (MDA) was calculated from the LSC counts of the alpha channels with a region of interest of 680-760 and PLI of 14 in the alpha-energy spectrum. The calculation of MDA was based on average counts (as specified above) for 2 h from urine samples collected from seven healthy adult donors using the method recommended by ANSI N13.30 (16) . The MDA of the present method was 0.15 Bq l 21 when a 40-ml aliquot of urine sample was used. As the MDA is Ra.
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inversely proportional to the volume of urine sample, it can be further lowered by using a larger volume of urine sample. However, in a radiological emergency it would be more practical to collect a small volume of 'spot sample' rather than a large volume. Nonetheless, the MDA of the present method is lower than the required sensitivity of 0.2 Bq l 21 for 226 Ra in human urine samples as defined in the requirements for radiation emergency bioassay techniques for the public and first responders based on the dose threshold for possible medical attention as recommended by the ICRP (5) .
Method accuracy and repeatability
The accuracy and repeatability were calculated based on quintuplicate measurements of 40-ml aliquots of a urine sample spiked with 2 Bq l 21 of 226 Ra. As described by Li et al. (5) , the spiking level (2 Bq l 21 ) was selected based on the concentration of 226 Ra that will be excreted in the urine sample from an ICRP reference man on the third day after an internal exposure (acute inhalation) equivalent to an effective dose of 0.1 Sv incurred in the first year following the event. As defined by ANSI N13.30, measurement accuracy and method repeatability are expressed as relative bias (B r ) and relative precision (S B ), respectively (16) . As shown in Table 1 , the relative bias for the individual measurements (B ri ) ranged from 27.8 to 21.6 %, indicating very good agreement between the spiked amounts and experimentally measured values. The overall relative bias (B r ) calculated as the average of the individual relative biases (B ri ) was found to be 24.5 %. When compared with the radiobioassay performance criteria, relative bias (B r ) met and exceeded the compliance level of +25 % (16) . Relative precision (S B ) from the quintuplicate measurement was found to be 2.6 %. Relative precision was also found to be compliant with the ANSI N13.30, which defines the performance criteria for a 40 % precision.
It is noteworthy to mention that the experimentally measured activities for 226 Ra, as shown in Table 1 , were calculated using Equation 1 where the combined efficiency (E C ) was assumed to be 1. Good agreement (with a relative bias, B r , 210 %) between the spiked activity and experimentally measured activity for 226 Ra for all the urine samples indicates that in most cases it may not be necessary to use a tracer or spike a second aliquot of the sample with known activity of 226 Ra in order to determine the value of E C as described in Equation 3 . This exemption can be very useful when a rapid analysis is in demand with an acceptable level of relative bias and precision.
Robustness: matrix effect from different urine samples
Composition of urine can be very different based on time of excretion, diet, age, person, gender, activity level (for example at rest or after some physical exercise), health condition (healthy or otherwise), etc. In order to assess the robustness of the method against the variation of urine matrix, recovery of 226 Ra was investigated using urine samples from seven different healthy adult donors. The per cent recoveries (+1 standard deviation, s) of 226 Ra from these different donors are shown in Figure 2 . Urine samples from each of the donors were measured in triplicate. As shown in Figure 2 , although there is a noticeable difference ( as much as 20 %) of spike recovery among some urine samples, an average recovery of .90 % was observed in all of the seven urine samples. Moreover, based on the spike recovery, the relative bias and relative precision from all of the seven urine samples met and exceeded the compliance level of ANSI N13.30 radiobioassay performance criteria. This indicates that the method is fairly robust against the matrix variability among different urine samples. Rn, 218 Po and 214 Po) in the LSC measurement by the a/b discrimination capability, the alpha-emitting daughters cannot be resolved completely from 226 Ra if they were co-extracted from urine sample during the DLLME process. As a result, if the DLLME process does not selectively extract 226 Ra from its daughter progenies, the later (daughter progenies) will contribute to a positive interference to its measurement through LSC. The 226 Ra standard (NIST SRM 4965) used in this study is old enough (reference date, 9 September 1991) to contain 222 Rn, 218 Po, 214 Po, 214 Pb and 214 Bi due the in-growth of its progenies and is well suited to demonstrate the selectivity of the DLLME process. A LS spectrum of the alpha-energy channels (600-900) of a urine sample (spiked with 2 Bq l 21 of 226 Ra) measured for 2 h immediately after DLLME is shown in Figure 3 (solid lines). A single peak in the LS spectrum (as shown in the solid lines in Figure 3 ) illustrates selective extraction of 226 Ra from its alpha-emitting daughter progenies. To illustrate it further, when the same sample was measured (for 2 h) after 30 d, in addition to the original 226 Ra peak, the LS spectrum (dotted lines in Figure 3) shows three more peaks due to the in-growth of 222 Rn, 218 Po and 214 Po, respectively. The selectivity of the DLLME process for 226 Ra from urine samples was also studied in the presence of actinides (namely, 233 U, 239 Pu and 241 Am). When an aliquot of a urine sample was spiked with an actinide in pair with 226 Ra and the measured activity was compared with a second aliquot of the urine that was spiked with 226 Ra only, there was no significant (statistically) difference between the two values for any of the actinides. This indicates that there was no interference contribution on the recovery of 226 Ra and the DLLME process was selective for extraction of 226 Ra from urine in the presence of the actinides.
Sample turnaround time
A detailed breakdown of the sample turnaround time for different steps of the sample preparation and measurement in LSC is shown in Figure 4 . As shown in Figure 4 , it takes ,5 h to analyse one sample completely. Taking advantage of the vacuum box manifold, six columns were prepared, preconditioned and were used in organic removal and decolourisation for six urine samples at the same time by one laboratory personnel in 4.5 h. As a result, it takes ,7.5 h to prepare six urine samples ready to be analysed by LSC. Also, the columns used in organic removal and decolourisation can be prepared ahead of time and be stored for an extended period of time as there is no microbial growth on the resin materials in the presence of 1 % HCl (used for preconditioning the materials). Using pre-packed and preconditioned columns for organic removal, a batch of six urine samples can be prepared (ready to be analysed by LSC) in ,3 h.
SUMMARY
A new radioanalytical method was developed for rapid determination of 226 Ra in human urine samples. Extraction and preconcentration of 226 Ra from a urine sample (40 ml) to an organic solvent (1.6 ml of toluene) was carried out through DLLME using dibenzo-21-crown-7 and hexafluoroacetylacetone as chelating ligands and acetonitrile as disperser and de-emulsifer solvents. The DLLME technique is selective for extraction of 226 Ra from its daughter progenies as well as in the presence of actinides, namely, 233 U, 239 Pu and 241 Am. As a result, it can provide accurate measurement of 226 Ra by LSC (with a/b separation capability) despite its inherently low-resolution capability to resolve the signals from the alpha-emitting progenies and actinides. The MDA for the method (0.15 Bq l
21
) is lower than the required sensitivity of 0.2 Bq l 21 for 226 Ra as defined in the requirements for radiation emergency bioassay techniques for the public and first responders based on the dose threshold for possible medical attention as recommended by the ICRP. The accuracy (expressed as relative bias, B r ) and repeatability (expressed as relative precision, S B ) of the method evaluated at the reference level (2 Bq l
) were found to be 24.5 % (B r ) and 2.6 % (S B ), respectively. The sample turnaround time was ,5 h for a single urine sample and ,20 h for a batch of six urine samples. Due to the semi-automated DLLME sample preparation and the compact design of the Hidex 300 SL LSC system, determination of 226 Ra can be carried out in a field deployable mobile laboratory. With a faster sample turnaround time combined with the potential to carry out the analysis in a mobile laboratory, the newly developed method has real potential to be used for emergency radiobioassay of 226 Ra in human urine samples following a radiological or nuclear incident of national significance.
